Tuberculosis vaccine candidate gets $550 million for final stage trial - The Washington Post
washingtonpost.comSubmitted by thewashingtonpost7104 in health
If the next steps are successful, M72 would be the first new vaccine in a century to target tuberculosis, a disease that killed 1.6 million people in 2021.